Association of Gastroesophageal Reflux With Malignancy of the Upper Aerodigestive Tract in Elderly Patients
- PMID: 29270624
- PMCID: PMC5839296
- DOI: 10.1001/jamaoto.2017.2561
Association of Gastroesophageal Reflux With Malignancy of the Upper Aerodigestive Tract in Elderly Patients
Abstract
Importance: Chronic inflammatory states have been linked to the development of malignancy. Gastroesophageal reflux disease (GERD) is a known risk factor for esophageal adenocarcinoma as the end result of chronic inflammatory changes.
Objective: To investigate the association of GERD with the risk of malignancy in the upper aerodigestive tract (UADT).
Design, setting, and participants: We used the Surveillance, Epidemiology, and End Results (SEER)-Medicare database to conduct a case-control study of individuals in the United States who had been added from January 2003 through December 2011 and were 66 years or older. The study included patients diagnosed with malignancy of the larynx, hypopharynx, oropharynx, tonsil, nasopharynx, and paranasal sinuses. GERD was examined as an exposure. Controls were matched from a 5% random sample of Medicare beneficiaries without cancer. Multivariable unconditional logistic regression was performed.
Main outcomes and measures: Incidence of invasive malignancies of the UADT.
Results: A total of 13 805 patients (median [range] age, 74 [66-99] years; 3418 women [24.76%] and 10 387 men [75.24%]) with malignancy of the UADT were compared with 13 805 patients without disease and were matched for sex, age group, and year of diagnosis. GERD was associated with a greater odds of developing malignancy of the larynx (adjusted odds ratio [aOR], 2.86; 95% CI, 2.65-3.09), hypopharynx (aOR, 2.54; 95% CI 1.97-3.29), oropharynx (aOR, 2.47; 95% CI, 1.90-3.23), tonsil (aOR, 2.14; 95% CI, 1.82-2.53), nasopharynx (aOR, 2.04; 95% CI, 1.56-2.66), and paranasal sinuses (aOR, 1.40; 95% CI, 1.15-1.70).
Conclusions and relevance: GERD is associated with the presence of malignancy of the UADT in the US elderly population. This epidemiological association requires further examination to determine causality and diagnostic utility.
Conflict of interest statement
Figures
Similar articles
-
Gastroesophageal reflux disease: A risk factor for laryngeal squamous cell carcinoma and esophageal squamous cell carcinoma in the NIH-AARP Diet and Health Study cohort.Cancer. 2021 Jun 1;127(11):1871-1879. doi: 10.1002/cncr.33427. Epub 2021 Feb 22. Cancer. 2021. PMID: 33615447 Free PMC article.
-
Prevalence of Eustachian Tube Dysfunction in the US Elderly Population.Otolaryngol Head Neck Surg. 2020 Dec;163(6):1169-1177. doi: 10.1177/0194599820932541. Epub 2020 Jun 23. Otolaryngol Head Neck Surg. 2020. PMID: 32573346
-
Increased risk of larynx cancer in patients with gastroesophageal reflux disease from a national sample cohort.Clin Otolaryngol. 2019 Jul;44(4):534-540. doi: 10.1111/coa.13328. Epub 2019 Apr 26. Clin Otolaryngol. 2019. PMID: 30884136
-
Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.JAMA. 2002 Apr 17;287(15):1972-81. doi: 10.1001/jama.287.15.1972. JAMA. 2002. PMID: 11960540 Review.
-
Gastroesophageal reflux disease and non-esophageal cancer.World J Gastroenterol. 2015 Jan 21;21(3):815-9. doi: 10.3748/wjg.v21.i3.815. World J Gastroenterol. 2015. PMID: 25624714 Free PMC article. Review.
Cited by
-
Unraveling the causality between gastroesophageal reflux disease and increased cancer risk: evidence from the UK Biobank and GWAS consortia.BMC Med. 2024 Aug 7;22(1):323. doi: 10.1186/s12916-024-03526-5. BMC Med. 2024. PMID: 39113061 Free PMC article.
-
Gastroesophageal reflux disease and risk of cancer: Findings from the Korean National Health Screening Cohort.Cancer Med. 2023 Sep;12(18):19163-19173. doi: 10.1002/cam4.6500. Epub 2023 Sep 7. Cancer Med. 2023. PMID: 37676071 Free PMC article.
-
Unraveling the Complexity of Regulated Cell Death in Esophageal Cancer: from Underlying Mechanisms to Targeted Therapeutics.Int J Biol Sci. 2023 Jul 31;19(12):3831-3868. doi: 10.7150/ijbs.85753. eCollection 2023. Int J Biol Sci. 2023. PMID: 37564206 Free PMC article. Review.
-
How I Approach Laryngopharyngoesophageal Reflux (LPR).Curr Gastroenterol Rep. 2021 Nov 19;23(12):27. doi: 10.1007/s11894-021-00823-4. Curr Gastroenterol Rep. 2021. PMID: 34799757 Review.
-
Gastroesophageal reflux disease: A risk factor for laryngeal squamous cell carcinoma and esophageal squamous cell carcinoma in the NIH-AARP Diet and Health Study cohort.Cancer. 2021 Jun 1;127(11):1871-1879. doi: 10.1002/cncr.33427. Epub 2021 Feb 22. Cancer. 2021. PMID: 33615447 Free PMC article.
References
-
- Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825-831. - PubMed
-
- Ness-Jensen E, Lindam A, Lagergren J, Hveem K. Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut. 2012;61(10):1390-1397. - PubMed
-
- Burke ZD, Tosh D. Barrett’s metaplasia as a paradigm for understanding the development of cancer. Curr Opin Genet Dev. 2012;22(5):494-499. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
